Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-23-007596
Filing Date
2023-03-14
Accepted
2023-03-14 16:05:34
Documents
12

Document Format Files

Seq Description Document Type Size
1 form424b4.htm 424B4 2820008
2 form424b4_001.jpg GRAPHIC 9359
3 form424b4_002.jpg GRAPHIC 76342
4 form424b4_003.jpg GRAPHIC 192792
5 form424b4_005.jpg GRAPHIC 15729
6 form424b4_006.jpg GRAPHIC 25106
7 form424b4_007.jpg GRAPHIC 18514
8 form424b4_008.jpg GRAPHIC 31534
9 form424b4_009.jpg GRAPHIC 16605
10 form424b4_010.jpg GRAPHIC 19347
11 form424b4_011.jpg GRAPHIC 31331
12 form424b4_012.jpg GRAPHIC 32897
  Complete submission text file 0001493152-23-007596.txt   3468672
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: 424B4 | Act: 33 | File No.: 333-268675 | Film No.: 23730724
SIC: 2836 Biological Products, (No Diagnostic Substances)